December #30 : An Aye for an Eye - by Scott Hess and Edited by RonniLyn Pustil

POZ - Health, Life and HIV
Subscribe to:
POZ magazine
E-newsletters
Join POZ: Facebook MySpace Twitter Pinterest
Tumblr Google+ Flickr MySpace
POZ Personals
Sign In / Join
Username:
Password:

Back to home » Archives » POZ Magazine issues




Table of Contents

Wild Kingdom

Rx Marijuana

Gender Matters

The Fabulous One

Mailbox

S.O.S.

Resistance Gets a Wellcome

Name in Vain

Go Figure

Like Butt-ah

An Aye for an Eye

To Russia Without Love

The Odd Couple

Secondhand Dose

Law and Disorder

AIDS in 2003

Catholic Cleanup

Until the Cure

Say What--December 1997

Diana, Princess of Wales

Chaka Treatment

Bear Essentials

Brace Yourself

All That Jazz

Respect Your Elders!

Bill of Health

Nunz With Attitude

POZ Picks-December 1997

Don't Mess With Mama

All Yesterday's Parties

The Light Burns Out

Peace of My Heart

Swing Your Partner

Once Upon a Lazarus

The Grim Reefer

In Case of Emergency

A DJ Saved My Life

Sweetness and Blight

"The First Cure"

Breaks for the Aches

Fishing for Supplements

When HIV Drugs Fail

Mary Fisher Gets Mad

Music Is Medicine



Most Popular Lessons

The HIV Life Cycle

Shingles

Herpes Simplex Virus

Syphilis & Neurosyphilis

Treatments for Opportunistic Infections (OIs)

What is AIDS & HIV?

Hepatitis & HIV


email print

December 1997

An Aye for an Eye

by Scott Hess and Edited by RonniLyn Pustil

Anti-CMV device gets the wink, with warnings

A new implant may put an end to needles in the eye for PWAs with CMV retinitis. "Patients didn't appreciate weekly eye injections," said Dr. David Musch, a University of Michigan researcher who helped develop the treatment. The device-a tiny ganciclovir-packed disk surgically fastened to the white of the eye-can be effective for up to six months, and then replaced. The original syringe treatment needed tending about every 70 days. One "implant" hitch bound to twitch eyebrows: The virus is more likely to creep into your other, untreated eye. A potential solution? Oral. "The other eye is susceptible to the same condition because the virus is systemic," said Munsch, adding that the old IV sticker delivered drug automatically to both eyes. "We give the patient an oral tablet in hopes of protecting the other eye." Research is under way to determine the effectiveness of this one-two-punch. The hope is that a steady supply of ganciclovir to the retina can halt CMV's progress and damage to your sight. "Over 5,000 units have been successfully implanted to date-all in HIV patients," said a rep of the implant manufacturer, Chiron Vision.



[Go to top]

Join POZ Facebook Twitter Google+ MySpace YouTube Tumblr Flickr
Quick Links
Current Issue

HIV 101
HIV Testing
Safer Sex
Find a Date
Newly Diagnosed
Disclosing Your Status
Starting Treatment
Search for the Cure
POZ Stories
POZ TV
Read the Blogs
Visit the Forums
Women
African American
Latino
Providers
Job Listings
Events Calendar


    Hillcrester
    Ramona
    California


    zeze42
    Bay Area - Peninsula
    California


    Deelight4u
    BROOKLYN
    New York


    Fergie911
    Chicago
    Illinois
Click here to join POZ Personals!
Ask POZ Pharmacist

Talk to Us
Poll
Can social media help stop HIV stigma?
Yes
No

Survey
Mind Matters

more surveys
Contact Us
We welcome your comments!
[ about Smart + Strong | about POZ | POZ advisory board | partner links | advertising policy | advertise/contact us | site map]
© 2014 Smart + Strong. All Rights Reserved. Terms of use and Your privacy.
Smart + Strong® is a registered trademark of CDM Publishing, LLC.